First Tracks Biotherapeutics Files Initial Ownership Statement
Ticker: TRAX · Form: 3 · Filed: 2026-04-01T16:33:35-04:00
Sentiment: neutral
Topics: insider-filing, ownership, biotech
TL;DR
FTXB filed a Form 3 on 4/1/26 - new ownership info.
AI Summary
On April 1, 2026, First Tracks Biotherapeutics, Inc. filed a Form 3, an initial statement of beneficial ownership of securities. The filing was made by Daniel Faga, who is listed with a mailing and business address in San Diego, CA. The company, with CIK 0002091349, is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing indicates a new ownership disclosure for First Tracks Biotherapeutics, Inc., potentially signaling new stakeholders or changes in insider holdings.
Risk Assessment
Risk Level: low — A Form 3 filing is a standard initial disclosure and does not inherently represent a change in the company's financial health or market position.
Key Numbers
- 0002091349 — Issuer CIK (Unique identifier for First Tracks Biotherapeutics, Inc.)
- 0001673528-26-000009 — Accession Number (Unique identifier for this specific SEC filing.)
- 2026-04-01 — Filing Date (Date the Form 3 was filed with the SEC.)
Key Players & Entities
- First Tracks Biotherapeutics, Inc. (company) — Issuer
- Daniel Faga (person) — Reporting Person
- 0002091349 (company) — Issuer CIK
- 0001673528-26-000009 (filing_id) — SEC Accession Number
- 2026-04-01 (date) — Filing Date and Period of Report
FAQ
What type of securities does this Form 3 filing relate to?
The filing is an initial statement of beneficial ownership of securities, but the specific types and amounts are not detailed in the provided text.
Who is the reporting person in this filing?
Daniel Faga is identified as the reporting person.
What is the business address of First Tracks Biotherapeutics, Inc.?
The business address is 10770 WATERIDGE CIRCLE SUITE 210 SAN DIEGO CA 92121.
When was this Form 3 filing accepted by the SEC?
The filing was accepted on 2026-04-01 at 16:33:35.
What industry does First Tracks Biotherapeutics, Inc. operate in?
The company operates in the Pharmaceutical Preparations sector (SIC 2834).
From the Filing
EDGAR Filing Documents for 0001673528-26-000009 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 3 - Initial statement of beneficial ownership of securities: SEC Accession No. 0001673528-26-000009 Filing Date 2026-04-01 Accepted 2026-04-01 16:33:35 Documents 1 Period of Report 2026-04-01 Document Format Files Seq Description Document Type Size 1 form3-04012026_080431.html 3 1 form3-04012026_080431.xml 3 1788 Complete submission text file 0001673528-26-000009.txt 3337 Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 Business Address Faga Daniel ( Reporting ) CIK : 0001673528 (see all company filings) Type: 3 | Act: 34 | File No.: 001-43177 | Film No.: 26828798 Mailing Address 10770 WATERIDGE CIRCLE SUITE 210 SAN DIEGO CA 92121 Business Address 10770 WATERIDGE CIRCLE SUITE 210 SAN DIEGO CA 92121 212-373-3000 First Tracks Biotherapeutics, Inc. ( Issuer ) CIK : 0002091349 (see all company filings) EIN. : 395003207 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)